Outcomes
| DAWN eligible (>24 hours since TLKW) n=21 | DAWN trial intervention arm n=107 | P values | |
| Procedural outcomes, n (%) | |||
| Rates of TICI ≥2b | 17 (81%) | 90 (84%) | 0.72 |
| Efficacy outcomes, n (%) | |||
| Early neurological recovery | 6 (29%) | 51 (48%) | 0.10 |
| mRS 0–2 at 90 days | 9 (43%) | 51 (48%) | 0.68 |
| Safety outcomes, n (%) | |||
| Neurologic deterioration | 2 (10%) | 15 (14%) | 0.57 |
| Symptomatic ICH | 1 (5%) | 6 (6%) | 0.87 |
| Mortality | 4 (19%) | 20 (19%) | 0.96 |
ICH, intracranial hemorrhage; mRS, modified Rankin Scale; TICI, Thrombolysis in Cerebral Infarction; TLKW, time last known well.